Tuberculin Skin Test and CD4+/CD8+ T Cell Counts in Adults Infected with the Human Immunodeficiency Virus in Medellín, Colombia

Memorias do Instituto Oswaldo Cruz

Volumn 92, Issue 2, 1997, Pages 245-250

  Rodriguez J I ^a   Arias, M ^a   Paris S C ^a   Arbelaez M P ^a   Betancur, J ^a   Garcia L F ^a  

^a UNIVERSIDAD DE ANTIOQUIA   (Colombia)

Author keywords

BCG vaccination; CD4; CD8; HIV; Tuberculin

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; MYCOBACTERIUM BOVIS BCG;

BCG VACCINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CD4 CD8 RATIO; CD4 LYMPHOCYTE COUNT; COLOMBIA; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; PREVALENCE; TUBERCULIN TEST;

ADOLESCENT; ADULT; BCG VACCINE; CD4 LYMPHOCYTE COUNT; CD4-CD8 RATIO; COLOMBIA; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; TUBERCULIN TEST;

EID: 0031083531     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761997000200018     Document Type: Article

References (20)

1. Alzate A, Crespo MP, Carrasquilla G, Corral R, Sánchez N, Muñoz A 1993. Purified protein derivative (PPD) and HIV infection in Cali, Colombia. J AIDS 6: 630-631.
2. Barnes PF, Le HQ, Davidson PT 1993. Tuberculosis in patients with HIV infection. Med Clin N Am 77: 1369-1390.
3. Bothamley GH, Beck JS, Potts RC, Grange JM, Kardjito TH, Ivanyi J 1992. Specificity of antibodies and tuberculin response after occupational exposure to tuberculosis. J Infect Dis 166: 182-186.
4. CDC - Centers for Disease Control 1990a. Screening for tuberculosis and tuberculous infecion in high risk populations: Recommendations of the Advisory Committee for Elimination of Tuberculosis. MMWR 39: 1-7.
5. CDC - Centers for Disease Control 1990b. Tuberculin reactions in apparently healthy HIV-seropositive and HIV-seronegative women-Uganda. International notes. MMWR 39: 638-646.
6. CDC - Centers for Disease Control 1991. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR 40(RR-5): 27-33.
7. + cell changes after HIV-1 infection indicate the existance of a codeterminant of AIDS. J Acquir Immune Defic Syndr 1: 390-395.
8. Graham NM, Nelson KE, Solomon L, Bonds M, Rizzo RT, Skavotto J, Astemborski JL, Vlahov D 1992. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA 267: 369-373.
9. Huebner RE, Schein MF, Bass JB 1993. The tuberculin skin test. Clin Infect Dis 17: 968-975.
10. Jones BE, Young SMM, Antoniskis D, Davidson PT, Kramer F, Barnes PF 1993. Relationship of the manifestations of tuberculosis to CD4 cell counts in patients with human immunodeficiency virus infection. Am Rev Resp Dis 148:1292-1297.
11. Lang W, Perkins H, Anderson RE, Royce RA, Jewell N, Winkelstein W 1989. Patterns of T lymphocyte changes with human immunodeficiency virus infection: from seroconversion to the development of AIDS. J Acquir Immune Defic Syndr 2: 63-69.
12. Larsson LO, Magnusson M, Skoogh B-E, Lind A 1992. Sensitivity to sensitins and tuberculin in Swedish children. IV. The influence of BCG vaccination. Eur Respir J 5: 584-586.
13. Markowitz N, Hansen N, Wilcosky TC, Hopewell PC, Glassroth J, Kvale PA, Mangura BT, Osmond D, Wallace JM, Rosen MJ, Reichman LB 1993. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Int Med 119: 185-193.
14. Orme IM, Andersen P, Boom WH 1993. T cell response to Mvcobacterium tuberculosis. J Infect Dis 167: 1481-1497
15. Pesanti EL 1994. The negative tuberculin test. Tuberculin, HIV and Anegry panels. Am J Respir Crit Care Med 149: 1699-1709,
16. Raviglione MC, Narain JP, Kochi A 1992. HIV-associated tuberculosis in developing countries: Clinical features, diagnosis and treatment. Bull WHO 70:515-526.
17. Rieder HL. Cauthen GM, Kelly GD, Bloch AB, Snider DE 1989. Tuberculosis in the United States. JAMA 262: 385-389.
18. Sears SD, Fox R, Brookmeyer R, Leavitt R, Polk BF 1987. Delayed hypersensitivity skin testing and anergy in a population of gay men. Clin Immunol Immunopathol 45: 177-183.
19. Selwyn PA, Hartel D, Lewis VA 1989. A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection. N Eng J Med 320: 545-550.
20. Yamagami M, Lum LG 1992. Bone Marrow Transplantation, p. 187-190. In NR Rose, E Conway de Macario, JL Fahey, H Friedman, GM Penn (eds) Manual of Clinical Laboratory Immunology. 4th Ed., American Society for Microbiology, Washington D.C.